From the bench
to the first round.
We partner before there’s a company to partner with, alongside the founders and the tech transfer offices that hold the science.
Five moves.
Listen
Source at the boundary, labs, tech transfer offices, clinicians, before the science is shopped.
Diligence
Assess the mechanism, the IP, the founder, the path to clinic and market. Literacy, not box-ticking.
Form & fund
Help structure the spinout and write the first institutional check.
Build
Take a board or advisory seat. Hiring, regulation, commercialization, cadence.
Bridge
Position for the priced round and open the door to the right follow-on capital.
A reliable first call.
We understand the licensing process, move quickly, structure founder-fair terms, and help inventors become credible CEOs. A clear yes or a clear no, and when it’s yes, capital and help that arrive.
We’ve made the leap.
From researcher or clinician to founder is the hardest transition there is. We bring operating experience, regulatory and go-to-market literacy, and a network, to your earliest, most fragile decisions.
We don’t just fund the company. We help build it.
Sonnerie takes board and advisory positions in the companies we back. It’s how we add value, and how we hold ourselves accountable to founders.
Team, first hires, operating cadence.
The FDA pathway and the first commercial wedge.
Warm introductions to the right seed and Series A.
Founder, inventor,
or tech transfer lead?
If you’re carrying science that deserves to become a company, talk to us early.